TrialJournal of immunology (Baltimore, Md. : 1950)2007
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
Daniel J Powell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
84 papers cite itlatest 60 shown
this papertrialcites it